Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Pivotal bioVenture Partners
AddedFeb 13, 2024
UpdatedJul 16, 2026
Pivotal bioVenture Partners

Pivotal bioVenture Partners

Operating

Pivotal Bioventure Partners: A California-based venture capital firm investing in early-stage biotech companies.

Location
San Francisco, CA, US
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Pivotal bioVenture Partners is a life sciences venture capital firm investing in transformative therapeutic-focused healthcare companies across North America and Europe. They focus on early-stage biotechnology companies, supporting ventures that develop high-impact therapeutics addressing major unmet medical needs.

The firm's portfolio includes notable companies such as Aligos Therapeutics, Arcutis Biotherapeutics, and Bolt Biotherapeutics. Pivotal bioVenture Partners typically invests in Series A to Series C rounds, with a strong emphasis on Series B investments. Their global approach and specialized focus on life sciences position them as a key player in the biotech investment landscape.

Pivotal bioVenture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments15
Current Portfolio Count10
Total Portfolio Exits0

Top Investment Stages

Series B7 (46.7%)
Series C4 (26.7%)
Series A2 (13.3%)
Convertible Note1 (6.7%)
Seed1 (6.7%)

Stage Mix

Series B 47%Series C 27%Series A 13%Convertible Note 7%Seed 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Avalyn Pharma logo

Avalyn Pharma

Evommune logo

Evommune

Plexium logo

Plexium

Arkuda Therapeutics logo

Arkuda Therapeutics

HotSpot Therapeutics logo

HotSpot Therapeutics

Obsidian Therapeutics logo

Obsidian Therapeutics

Bolt Biotherapeutics logo

Bolt Biotherapeutics

Aligos Therapeutics logo

Aligos Therapeutics

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

Stealth BioTherapeutics logo

Stealth BioTherapeutics

Pivotal bioVenture Partners - Similar Investment Firms

Pivotal bioVenture Partners China logo

Pivotal bioVenture Partners China

pivotalbiovp.cn

Nan Fung Life Sciences logo

Nan Fung Life Sciences

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Avalon BioVentures logo

Avalon BioVentures

Bioventures Investors logo

Bioventures Investors

Alta Partners logo

Alta Partners

altapartners.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Westlake Village BioPartners logo

Westlake Village BioPartners

westlakebio.com

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

Mission Bay Capital logo

Mission Bay Capital

Pandect Bioventures logo

Pandect Bioventures

pandectbio.com

Partner Ventures logo

Partner Ventures

partnervc.com

Accele Venture Partners logo

Accele Venture Partners

Solas BioVentures logo

Solas BioVentures

solasbio.com

Pivotal Capital logo

Pivotal Capital

pivotalcp.com

Pivotal bioVenture Partners - Classification

Also Known As
  • Pivotal Bioventure Partners Investment Advisor LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end